The PE Ratio as of December 2024 (TTM) for Cytek Biosciences, Inc. (CTKB) is -81.12

According to Cytek Biosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -81.12. This represents a change of -267.47% compared to the average of 48.44 of the last 4 quarters.

Cytek Biosciences, Inc. (CTKB) Historical PE Ratio (quarterly & annually)

How has CTKB PE Ratio performed in the past?

The mean historical PE Ratio of Cytek Biosciences, Inc. over the last ten years is 181.20. The current -81.12 PE Ratio has changed -4576.75% with respect to the historical average. Over the past ten years (40 quarters), CTKB's PE Ratio was at its highest in in the December 2021 quarter at 1.96K. The PE Ratio was at its lowest in in the March 2020 quarter at -664.24.

Cytek Biosciences, Inc. (CTKB) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Cytek Biosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cytek Biosciences, Inc. (CTKB) Average PE Ratio

How has CTKB PE Ratio performed in the past?

The current PE Ratio of Cytek Biosciences, Inc. (CTKB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Cytek Biosciences, Inc. (CTKB) PE Ratio vs. Peers

How is CTKB’s PE Ratio compared to its peers?

Cytek Biosciences, Inc.’s PE Ratio is less than Heska Corporation (-67.36), less than OrthoPediatrics Corp. (-18.39), less than Electromed, Inc. (39.18), less than Pulmonx Corporation (-4.24), less than RxSight, Inc. (-44.68), less than AxoGen, Inc. (-49.87), less than Treace Medical Concepts, Inc. (-7.05), less than Orthofix Medical Inc. (-5.61), less than NeuroPace, Inc. (-11.68), less than Inogen, Inc. (-3.80), less than Surmodics, Inc. (-48.78), less than Apyx Medical Corporation (-2.15), less than ProSomnus, Inc. (-0.59), less than LivaNova PLC (107.29), less than Sight Sciences, Inc. (-3.55), less than STRATA Skin Sciences, Inc. (-1.24), less than Vapotherm, Inc. (7.14), less than Talis Biomedical Corporation (-0.06),

Build a custom stock screener for Cytek Biosciences, Inc. (CTKB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cytek Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cytek Biosciences, Inc. (CTKB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cytek Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.